Sharekhan

Solara Active Pharma Sciences Ltd

Wed 21/05/2025,15:56:55 NSE: SOLARA

₹ 478.70 4.80 (1.01%)
BUY NOW Buy Solara Active Pharma Sciences Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock Solara Active Pharma Sciences Ltd

Wed 21/05/2025,16:1:0

Solara Active Pharma Sciences Ltd

Wed 21/05/2025,15:56:55 | NSE : SOLARA

₹ 478.704.80 (1.01%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 474.00

Previous Close

₹ 473.90

Volume

84506

Mkt Cap ( Rs. Cr)

₹2117.78

High

₹ 483.45

Low

₹ 472.05

52 Week High

₹ 882.80

52 Week Low

₹ 366.70

Book Value Per Share

₹ 247.00

Dividend Yield

0.00

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Solara Active Pharma Sciences Ltd

Your Vote -

Buy

88.24%

Hold

5.29%

Sell

6.47%

88.24%

170 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

100%

Sell Order Quantity

0%

Bid Price

Qty

478.70

310

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

310

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Solara Active Pharma Sciences Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Solara Active Pharma - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    16 May 2025, 5:43PM Solara Active Pharma Sciences Limited has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Shar

  • Solara Active Pharma - Copy of Newspaper Publication

    16 May 2025, 1:33PM Solara Active Pharma Sciences Limited has informed the Exchange about Copy of Newspaper Publication made on May 16, 2025 wherein Financial Results for

  • Solara Active Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    15 May 2025, 7:43PM Solara Active Pharma Sciences Limited, has informed the exchange regarding the outcome of the Investors' conference call for the quarter ended March 3

  • Solara Active Pharma - Analysts/Institutional Investor Meet/Con. Call Updates

    15 May 2025, 7:24PM Solara Active Pharma Sciences Limited has informed the Exchange about Link of Recording

  • Solara Active Pharma - Change in Auditors

    15 May 2025, 7:19PM Solara Active Pharma Sciences Limited has informed the Exchange regarding Change in Auditors of the company.

  • Solara Active Pharma - Appointment Of Internal Auditors, Secretarial Auditor And Reappointment Of Cost Auditor.

    15 May 2025, 5:30PM Solara Active Pharma Sciences Limited has informed the Exchange regarding the Appointment of Internal, Secretarial Auditor and Reappointment of Cost A

  • Solara Active Pharma - Retirement

    15 May 2025, 5:17PM Solara Active Pharma Sciences Limited, has informed the exchange regarding the retirement of Mr. S. Murali Krishna from the position of the Company Se

  • Solara Active Pharma - Appointment

    15 May 2025, 5:17PM Solara Active Pharma Sciences Limited has informed the Exchange regarding Appointment of Mrs Pooja Jayakumar as Company Secretary & Compliance Office

  • Solara Active Pharma - Appointment of Company Secretary and Compliance Officer

    15 May 2025, 5:15PM Solara Active Pharma Sciences Limited has informed the Exchange regarding Appointment of Company Secretary, Compliance officer and Key Managerial Pers

  • Solara Active Pharma - Announcement under Regulation 30 (LODR)-Retirement

    15 May 2025, 5:11PM Solara Active Pharma Sciences Limited has informed the Exchange regarding Retirement of Company Secretary and Compliance officer

  • Solara Active Pharma - Statement of deviation(s) or variation(s) under Reg. 32

    15 May 2025, 4:58PM Solara Active Pharma Sciences Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32

  • Solara Active Pharma - Press Release

    15 May 2025, 4:58PM Solara Active Pharma Sciences Limited, has informed the exchange regarding the Press release in connection with Financial Results for the quarter and

  • Solara Active Pharma - Announcement under Regulation 30 (LODR)-Change in Management

    15 May 2025, 4:55PM Solara Active Pharma Sciences Limited has informed the exchange regarding Resignation and Appointment of Company Secretary and Compliance officer

  • Solara Active Pharma - Statement Of Deviation And Variation

    15 May 2025, 4:44PM Solara Active Pharma Sciences Limited has informed the Exchange that there is no Deviation and Variation of Funds raised through Rights Issue for Quar

  • Solara Active Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    15 May 2025, 4:41PM Solara Active Pharma Sciences Limited has informed the Exchange regarding Press Release for the Board Meeting held on May 15, 2025 on Q4 of FY 25

  • Solara Active Pharma posts Q4 net loss of Rs 4.88 cr

    15 May 2025, 2:40PM The company reported standalone net loss during the quarter stood at Rs 4.88 crore as compared to net loss of Rs 256.40 crore in the previous year qua

  • Solara Active Pharma - Outcome of Board Meeting

    15 May 2025, 2:29PM Solara Active Pharma Sciences Limited has informed the exchange regarding inter alia, the Audited Standalone and Consolidated Financial Results for th

  • Solara Active Pharma - Board Meeting Outcome for Audited Financial Results For The Quarter And Year Ended March 31, 2025

    15 May 2025, 2:26PM Solara Active Pharma Sciences Limited has informed the Exchange regarding inter alia, the Audited Standalone and Consolidated Financial Results for th

  • Solara Active Pharma - Audited Financial Results For The Quarter And Year Ended March 31, 2025

    15 May 2025, 2:24PM Solara Active Pharma Sciences Limited has informed the exchange regarding inter alia, the Audited standalone and Consolidated Financial Results for th

  • Solara Active Pharma - Press Release

    10 May 2025, 3:43PM Solara Active Pharma Sciences Limited has informed the Exchange regarding a press release dated May 10, 2025, titled ""Completion of USFDA inspection

  • Solara Active Pharma - Announcement Under Regulation 30 - Press Release

    10 May 2025, 3:41PM Solara Active Pharma Sciences Limited has informed the exchange regarding the press release of completion of USFDA Inspection in Ambernath facility.

  • Solara Active Pharma - Analysts/Institutional Investor Meet/Con. Call Updates

    8 May 2025, 12:56PM Solara Active Pharma Sciences Limited has informed the exchange regarding the conference call scheduled with the investors and analysts on Thursday, M

  • Solara Active Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    8 May 2025, 12:54PM Solara Active Pharma Sciences Limited has informed the exchange regarding the conference call scheduled with the investors and analysts on Thursday, M

  • Solara Active Pharma - Board Meeting Intimation

    7 May 2025, 3:13PM SOLARA ACTIVE PHARMA SCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 15-May-2025 to inter-alia consider and approve the A

  • Solara Active Pharma - Monitoring Agency Report

    7 May 2025, 1:16PM Solara Active Pharma Sciences Limited has informed the Exchange regarding submission of Monitoring Agency Report for the quarter ended March 31, 2025

  • Solara Active Pharma - Board Meeting Intimation for Board Meeting Intimation

    7 May 2025, 3:03PM Solara Active Pharma Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2025 ,inter alia, to

  • Solara Active Pharma - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

    7 May 2025, 1:13PM Solara Active Pharma Sciences Limited has informed the Exchange regarding submission of Monitoring Agency Report for the quarter ended March 31, 2025

  • Solara Active Pharma - Committee Meeting Updates

    6 May 2025, 3:47PM Solara Active Pharma Sciences Limited has informed the Exchange regarding 'Outcome of the Rights Issue Committee Meeting - Receipt of the First Call m

  • Solara Active Pharma - Board Meeting Outcome for Board Meeting Outcome For The Rights Issue Committee Meeting - Receipt Of Fi

    6 May 2025, 3:45PM Solara Active Pharma Sciences Limited has informed the Exchange regarding Outcome of Rights Issue Committee Meeting -Receipt of the First Call Money i

  • Solara Active Pharma - Address Change

    5 May 2025, 3:07PM Solara Active Pharma Sciences Limited has informed the Exchange regarding change in Corporate Office address of the company.

  • Solara Active Pharma - Announcement under Regulation 30 (LODR)-Change in Corporate Office Address

    5 May 2025, 2:59PM Solara Active Pharma Sciences Limited has informed the Exchange regarding Change in Corporate Office address.

  • Solara Active Pharma - Announcement under Regulation 30 (LODR)-Change in Registered Office Address

    5 May 2025, 2:55PM Solara Active Pharma Sciences Limited has informed the Exchange regarding Change in the Registered Office of the Company within the local limits of th

  • Solara Active Pharma - General Updates

    29 Apr 2025, 4:23PM Solara Active Pharma Sciences Limited has informed the Exchange about the Incorporation of Wholly Owned Subsidiary Company in the name of ""Synthix Gl

  • Solara Active Pharma - Incorporation Of Wholly Owned Subsidiary Company

    29 Apr 2025, 4:18PM Solara Active Pharma Sciences Limited has informed the Exchange regarding the Incorporation of Wholly Owned Subsidiary Company in the name of \Synthix

  • Solara Active Pharma has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    20 Apr 2025, 7:00AM As of March 2025, 37.94% is owned by Indian Promoters and 62.06% by Public. <p align=justify> Top five Promoters holding highest number of shares of S

  • Solara Active Pharma - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    17 Apr 2025, 4:00PM Solara Active Pharma Sciences Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the

  • Solara Active Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    17 Apr 2025, 3:55PM Solara Active Pharma Sciences Limited has informed the exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the

  • Solara Active Pharma - General Updates

    9 Apr 2025, 1:02PM Solara Active Pharma Sciences Limited has informed the Exchange about dispatch of Notice to the eligible shareholders of the First call money of the R

  • Solara Active Pharma - Copy of Newspaper Publication

    9 Apr 2025, 1:02PM Solara Active Pharma Sciences Limited has informed the Exchange about Copy of Newspaper Publication made by the Company on the Record date fixed for t

  • Solara Active Pharma - Notice On The First Call Money Of The Rights Equity Shares.

    9 Apr 2025, 1:34PM Solara Active Pharma Sciences Limited has informed the Exchange about dispatch of Notice to the eligible shareholders of the First Call Money of the R

  • Solara Active Pharma - Outcome of Board Meeting

    2 Apr 2025, 3:49PM Solara Active Pharma Sciences Limited has informed the Exchange regarding Rights Issue Committee Meeting held on April 02, 2025 interalia, to conside

  • Solara Active Pharma - Board Meeting Outcome for Outcome Of The Rights Issue Committee Meeting_Solara Active Pharma Sciences

    2 Apr 2025, 4:00PM Outcome: Solara Active Pharma Sciences Limited informed the exchange about the Rights Issue Committee Meeting held today (i.e.) on April 02, 2025 inte

  • Solara Active Pharma - Announcement under Regulation 30 (LODR)-Meeting Updates

    2 Apr 2025, 3:55PM Solara Active Pharma Sciences Limited informed the exchange about the outcome of the Rights Issue Committee Meeting held today (i.e.) April 02, 2025 i

  • Solara Active Pharma - Suspension of Trading

    1 Apr 2025, 7:30PM Members of the Exchange are hereby informed that the trading in the partly paid-up equity shares (Series: E1, ISIN: IN9624Z01014) of Solara Active Pha

  • Solara Active Pharma - Board Meeting Intimation

    26 Mar 2025, 4:22PM SOLARA ACTIVE PHARMA SCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 02-Apr-2025 to consider Alteration of form or nature

  • Solara Active Pharma - Trading Window-XBRL

    26 Mar 2025, 4:00PM SOLARA ACTIVE PHARMA SCIENCES LIMITED has informed the Exchange about Closure of Trading Window

  • Solara Active Pharma - Trading Window

    26 Mar 2025, 3:57PM Solara Active Pharma Sciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading)

  • Solara Active Pharma - Record Date

    26 Mar 2025, 11:26AM Solara Active Pharma Sciences Limited has informed the Exchange that Record date for the purpose of Calls on Securities is 04-Apr-2025.

  • Solara Active Pharma - Rights Issue

    26 Mar 2025, 11:00AM Solara Active Pharma Sciences Limited has informed the Exchange that Board of Directors at its meeting held on March 26, 2025, has decided to issue eq

  • Solara Active Pharma - Board Meeting Intimation for Rights Issue Committee Meeting To Approve The Notice Of First Call To Be

    26 Mar 2025, 4:17PM Solara Active Pharma Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/04/2025 ,inter alia, to

  • Solara Active Pharma - Record Date For The Purpose Of Making First Call For Rights Issue Equity Shares

    26 Mar 2025, 11:16AM Solara Active Pharma Sciences Limited has informed the exchange about the Record date for the purpose of making first call for the shares issued on Ri

  • Solara Active Pharma - Board Meeting Outcome for Intimation Under Regulation 30 And 42 Of SEBI (Listing Obligations And Discl

    26 Mar 2025, 11:08AM Solara Active Pharma Sciences Limited has informed the Exchange that Board of Directors at its meeting held on March 26, 2025, has approved the making

  • Solara Active Pharma - Announcement under Regulation 30 (LODR)-Meeting Updates

    26 Mar 2025, 10:54AM Solara Active Pharma Sciences Limited had informed the Exchange that Rights Issue Commitee Meeting of the Board of Directors at its meeting held on Ma

  • Solara Active Pharma - Copy of Newspaper Publication

    21 Mar 2025, 1:38PM Solara Active Pharma Sciences Limited has informed the Exchange about Copy of Newspaper Publication published in Business Standard (English version) a

  • Solara Active Pharma - Notice Of Shareholders Meetings-XBRL

    20 Mar 2025, 4:01PM SOLARA ACTIVE PHARMA SCIENCES LIMITED has informed the Exchange about Notice of Shareholders Meeting for Postal Ballot

  • Solara Active Pharma - Shareholders meeting

    20 Mar 2025, 3:55PM Solara Active Pharma Sciences Limited has informed the Exchange regarding Notice of Postal Ballot of the Company for obtaining Members' approval in co

  • Solara Active Pharma - Board Meeting Intimation

    20 Mar 2025, 3:37PM SOLARA ACTIVE PHARMA SCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 26-Mar-2025 to consider Alteration of form or nature

  • Solara Active Pharma - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

    20 Mar 2025, 3:57PM Notice of the Postal Ballot of the Company for obtaining Members' approval to consider the appointment of Mr. Sandeep Shashikantha Rao as a Managing D

  • Solara Active Pharma - Board Meeting Intimation for Rights Issue Committee Meeting For Making The First Call Of The Shares I

    20 Mar 2025, 3:28PM Solara Active Pharma Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/03/2025 ,inter alia, to

  • Solara Active Pharma - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    21 Feb 2025, 6:24PM SOLARA ACTIVE PHARMA SCIENCES LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Shar

  • Solara Active Pharma - Updates

    21 Feb 2025, 6:06PM Solara Active Pharma Sciences Limited has informed the Exchange regarding grant of 3,50,000 ESOP as per the Solara ESOP 2024.

  • Solara Active Pharma - General Updates

    21 Feb 2025, 6:06PM Solara Active Pharma Sciences Limited has informed the Exchange regarding Closure of Wholly Owned Subsidiary, Solara Active Pharma Sciences LTDA, Braz

  • Solara Active Pharma - Change in Management

    21 Feb 2025, 6:06PM Solara Active Pharma Sciences Limited has informed the Exchange about change in Chief Financial Officer (i.e.) from Resignation of Mr. Arun Kumar Bask

  • Solara Active Pharma - Change in Director(s)

    21 Feb 2025, 6:06PM Solara Active Pharma Sciences Limited has informed the Exchange regarding Change in Director(s) of the company.

  • Solara Active Pharma - Grant Of ESOP Options

    21 Feb 2025, 5:58PM Solara Active Pharma Sciences Limited has informed the Exchange about Grant of ESOP Options.

  • Solara Active Pharma - Closure Of Wholly Owned Subsidiary

    21 Feb 2025, 5:52PM Solara Active Pharma Sciences Limited has informed the Exchange regarding the Closure of Wholly Owned Subsidiary of the Company.

  • Solara Active Pharma - Announcement under Regulation 30 (LODR)-Resignation of Managing Director

    21 Feb 2025, 5:39PM Solara Active Pharma Sciences Limited has informed the Exchange regarding Resignation of Managing Director.

  • Solara Active Pharma - Announcement under Regulation 30 (LODR)-Change in Management

    21 Feb 2025, 5:33PM Solara Active Pharma Sciences Limited has informed the Exchange regarding Appointment and Resignation of Chief Executive officer, Appointment and Resi

  • Solara Active Pharma - Announcement under Regulation 30 (LODR)-Change in Directorate

    21 Feb 2025, 5:24PM Solara Active Pharma Sciences has informed the Exchange regarding the appointment of a Managing Director.

  • Solara Active Pharma - Outcome of Board Meeting

    21 Feb 2025, 5:21PM Solara Active Pharma Sciences Limited has informed the Exchange regarding Outcome of Board Meeting held on February 21, 2025.

  • Solara Active Pharma - Outcome of Board Meeting

    21 Feb 2025, 5:16PM Solara Active Pharma Sciences Limited has informed the Exchange regarding Board meeting held on February 21, 2025 interalia to consider the appointmen

  • Solara Active Pharma - Board Meeting Outcome for Solara Active Pharma Sciences Limited Has Informed The Exchange Regarding Bo

    21 Feb 2025, 5:16PM Solara Active Pharma Sciences Limited has informed the Exchange regarding Board meeting held on February 21, 2025 interalia to consider Appointment an

  • Solara Active Pharma

    6 Jul 2023 , 10:51AM Solara Active Pharma has agreed to raise funds through the issue of equity shares of FV of Rs. 10 not exceeding Rs. 450 Cr. by the way of rights issue to eligible equity shareholder of the company. We do not have coverage on it.

  • Solara Active Pharma successfully completes EU GMP Inspection

    13 Feb 2023 , 12:14PM Completion of the EU-GMP inspection at the Cuddalore facility of the Company

  • Stock Update: Solara Active Pharma Science

    12 Nov 2021 , 11:50AM Stock Update: Solara Active Pharma Science Q2FY22 Results Update

  • Solara Active Pharma Sciences Q2Fy22 results

    11 Nov 2021 , 5:14PM Solara Active Pharma Sciences Q2Fy22 results – Weak quarter, results missed estimates

  • Solara Active Pharma Sciences: Q1FY22 Results update

    5 Aug 2021 , 10:59AM Solara Active Pharma Sciences Ltd: Q1FY22 Results update - Healthy quarter; Robust outlook

  • Solara Active Pharma Sciences Q1FY2022

    4 Aug 2021 , 3:31PM Solara Active Pharma Sciences Q1FY2022: Healthy quarter; results miss estimates

  • Solara announces CEP for Ranitidine Hydrochloride drug substance restored by EDQM

    2 Jul 2021 , 3:31PM Solara is the first company to have its CEP restored among Ranitidine API manufacturers

  • Solara Active Pharma Sciences

    2 Jul 2021 , 3:19PM Solara Active Pharma Sciences: Has announced that the EDQM ( European Directorate for the Quality of Medicines & HealthCare) has restored is CEP for Ranitidine Hydrochloride drug substance (API). Solara had put in place robust manufacturing and quality processes to mitigate the risks of N-Nitroso Dimethylamine (NDMA) formation in the Ranitidine HCL API and subsequent submission of the pertinent data has fast-tracked the restoration of CEP by EDQM. Solara is the only company to have its CEP for Ranitidine hydrochloride restored, hence positive

  • Solara Active Pharma Sciences

    1 Jun 2021 , 10:27AM The government of India has given approval to four waitlisted firms under the Production Linked Incentive (PLI) scheme for domestic manufacturing of bulk drugs. It envisages setting up greenfield plants in four different target segments with a total outlay of Rs 6,940 crore for the period 2020-21 to 2029-30.Now the Government has approved the application of 4 wait listed players who were eligible under the scheme. These include Solara Active Pharma Sciences, while the other companies being approved are Rajasthan Antibiotics Ltd, Dhatri Lab Pvt Ltd and Vital Laboratories Pvt Ltd. The products for which the approvals have been given are 1 Cyclohexane Diacetic Acid, Meropenem, Ritonavir and Levofloxacin. The receipt of the approval for PLI scheme is positive for Solara Active Pharma Sciences.

  • Solara Active Pharma Sciences: Q4FY2021 Result Update

    7 May 2021 , 11:10AM Solara Active Pharma Sciences: Q4FY2021 Result Update - Strong quarter; Robust outlook

  • Stock update - Solara Active Pharma Sciences

    13 Apr 2021 , 11:03AM Stock update - Solara Active Pharma Sciences : Synergetic Merger, Earnings accretive

  • Solara Active Pharma Sciences board approves merger of Aurore Life sciences

    12 Apr 2021 , 12:12PM Solara Active, Aurore Life combine to create second largest Pure Play API / CRAMs company in India

  • Solara Active Pharma Sciences

    12 Apr 2021 , 10:18AM Solara Active Pharma Sciences (Solara): Board approves merger of Aurore Life sciences in an all-stock deal; combined entity to be pure play API company of scale with strong presence in key markets, broad product portfolio and could strengthen Solara’s CRAMS business. We believe the merger would be positive as both the business are synergistic and would open up multiple growth avenues and enable to achieve operational efficiencies

  • Solara Active Pharma Sciences

    19 Feb 2021 , 9:09AM As per media news, The promoters along with TPG capital are said to be looking for an exit from the company. The total promoters stake stands at 44% while TPG Group had a stake of around 15%. The stake sale is likely to trigger an open offer.

  • Solara Active Pharma Sciences : Stock Update

    9 Dec 2020 , 12:04PM Solara Active Pharma Sciences : Stock Update – Growth Levers Intact

  • Solara Active Pharma announces interim dividend

    11 Nov 2020 , 12:20PM Solara Active Pharma Sciences board declares interim dividend of Rs. 4

  • Solara Active Pharma reports good Q2 earnings

    30 Oct 2020 , 3:12PM Solara Active Pharma: Strong operating performance leads to PAT beat

  • Solara Active Pharma Sciences

    16 Sep 2020 , 10:08AM Promoters Pronomz Ventures released pledge of 13.18 lakh shares on September 10, 2020. Post the release the proportion of pledged shares stands at 4.7% of the total promoters holdings down from 13%. The release of the pledged shares is positive

  • New Idea - Solara Active Pharma Sciences

    14 Sep 2020 , 11:40AM New Idea - Solara Active Pharma Sciences – Viewpoint - Well placed to harness API opportunities

  • Solara Active Pharma completes USFDA inspection at SRC

    17 Dec 2018 , 11:35AM Solara Research Centre (SRC) completes USFDA Inspection with Zero 483s
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Solara Active Pharma Sciences Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 1872.27 1936.8 2504.28 2551.62 2108.49
Liabilities 1872.27 1936.8 2504.28 2551.62 2108.49
Equity 40.25 36 36 36 35.92
Gross Profit 203.84 -95.06 134.04 80.35 385.33
Net Profit -1.08 -566.87 -22.21 -58.56 220.96
Cash From Operating Activities 212.8 110.95 156.17 -241.77 154.44
NPM(%) -0.08 -43.98 -1.53 -4.61 13.66
Revenue 1283.76 1288.92 1443.81 1268.34 1616.88
Expenses 1079.92 1383.98 1309.77 1187.99 1231.55
ROE(%) -0.09 -51.87 -2.03 -5.35 20.22

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
18 Aug 2021 3 30 0 1648.75
19 Nov 2020 4 40 0 1095.5
28 Jul 2020 2 20 0 502.4
06 Aug 2019 5 50 0 442.1

Peers

Other companies within the same industry or sector that are comparable to Solara Active Pharma Sciences Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 810.15 -0.84 26.88 270.41 301.39 0.62
Lotus Eye Hospital and Institute Ltd 74.06 0.78 308.58 985.33 14.01 0.68
Vaishali Pharma Ltd 12.85 -1.15 428.33 507.88 2.76 0.00
Astec Lifesciences Ltd 701.25 -1.59 0.00 929.08 -687.11 0.00

Company Info

Our Company was originally incorporated on February 23, 2017 under the Companies Act, 2013 as SSL Pharma Sciences Limited with the RoC. The name of the Company was changed to Solara Active Pharma Sciences Limited and a fresh certificate of incorporation was issued by the RoC on March 25, 2017. 2019 -Solara Active Pharma Sciences Limited said that, “it has successfully completed the US FDA inspection at the multi-product manufacturing facility at Cuddalore with ZERO 483s i 2021 -Solara Active Pharma approves acquisition of balance 10.77% stake in Sequent Penems 2023 -Solara Active Pharma Sciences completes WHO inspection at its Cuddalore facility. 2024 -The company issued rights shares of Rs. 10 in the ratio of 1:3 at a premium of Rs. 365 per share.

Our Company was originally incorporated on February 23, 2017 under the Companies Act, 2013 as SSL Pharma Sciences Limited with the RoC. The name of the Company was changed to Solara Active Pharma Sciences Limited and a fresh certificate of incorporation was issued by the RoC on March 25, 2017. 2019 -Solara Active Pharma Sciences Limited said that, “it has successfully completed the US FDA inspection at the multi-product manufacturing facility at Cuddalore with ZERO 483s i 2021 -Solara Active Pharma approves acquisition of balance 10.77% stake in Sequent Penems 2023 -Solara Active Pharma Sciences completes WHO inspection at its Cuddalore facility. 2024 -The company issued rights shares of Rs. 10 in the ratio of 1:3 at a premium of Rs. 365 per share.

Read More

Parent Organisation

Solara Active Pharma Sciences Ltd.

Founded

23/02/2017

Managing Director

Mr.Poorvank Purohit

NSE Symbol

SOLARAEQ

FAQ

The current price of Solara Active Pharma Sciences Ltd is ₹ 478.70.

The 52-week high for Solara Active Pharma Sciences Ltd is ₹ 483.45 and the 52-week low is ₹ 472.05.

The market capitalization of Solara Active Pharma Sciences Ltd is currently ₹ 2117.78. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Solara Active Pharma Sciences Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Solara Active Pharma Sciences Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Solara Active Pharma Sciences Ltd shares.

The CEO of Solara Active Pharma Sciences Ltd is Mr.Poorvank Purohit, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT